8-arm PEG-MAL (SUC)

SINOPEG is a dynamic science company with professional R&D, Manufacturing and Sales capability. The company is mainly engaged in drug delivery system (DDS) and new medical materials business. Founded in 2011, SINOPEG has a team of highly qualified and science background employee personnel. We devote ourselves to research, develop and produce high quality Polyethylene glycol, Polyethylene glycol derivatives, Block copolymers, Anti-diabetic drug side chains, lipids for LNPs, GalNAc conjugates, ADC and ProTAC Linker, etc.

Reference:

1. McTiernan CD, Simpson FC, Haagdorens M, et al. LiQD Cornea: Pro-regeneration collagen mimetics as patches and alternatives to corneal transplantation. Sci Adv. 2020;6(25):eaba2187. Published 2020 Jun 17. doi:10.1126/sciadv.aba2187
2. Buznyk, O.; Goodarzi, H.; Laguna, J.G.; Reddy, J.; Liszka, A.; Edin, E.; Boutopoulos, C.; Chodosh, J.; Islam, M.M.; Griffith, M. Collagen Analogs Promote Tissue Regeneration in HSV-1-Infected Corneas in Animal Models. J. Funct. Biomater. 2025, 16, 377, https://doi.org/10.3390/jfb16100377.